Treatment of isolated mitochondria with Ca 2+ and inorganic phosphate (P~) induces an inner membrane permeability that appears to be mediated through a cyclosporin A (CsA)-inhibitable Ca2+-dependent pore. Isolated mitochondria during inner membrane permeability undergo rapid effiux of matrix solutes such as glutathione as GSH and Ca 2+, loss of coupled functions, and large amplitude swelling. Permeability transition without large amplitude swelling, a parameter often used to assess inner membrane permeability, has been observed. The addition of either oligomycin, antimycin, or sulfide to incubation buffer containing Ca 2÷ and Pi abolished large amplitude swelling of mitochondria. The GSH status during a Ca 2÷-and P~-dependent mechanism of mitochondrial GSH release in isolated mitochondria was influenced significantly by metabolic inhibitors of the respiratory chain but did not prevent inner membrane permeability as demonstrated by the release of mitochondrial GSH and Ca 2+. The release of GSH was inhibited by the addition of CsA, a potent inhibitor of permeability transition. Under these conditions we did not find GSSG; however, rapid oxidation of pyridine nucleotides and depletion of ATP and ADP with conversion to AMP occurred. The addition of CsA, prevented the oxidation of pyridine nucleotides and depletion of ATP and ADP. Since NADH and NADPH were extensively oxidized, protection against oxidative stress is reflected in maintenance of GSH and not observable lipid peroxidation. Evidence from transmission electron microscopy analysis, combined with the GSH release data, indicate that permeability transition can be observed in the absence of large amplitude swelling.
Introduction
Without mitochondrial antioxidant defense systems such as the glutathione redox cycle, aerobic metabolism, an essential process for life in many species, would likely be impossible due to the endogenous formation of reactive oxygen species (ROS). It is estimated that nearly 90% of the total 02 consumed by mammalian species is delivered to mitochondria, where a four-electron reduction to H20 by the respiratory chain is coupled to ATP synthesis [1, 2] . Nearly 4% of mitochondrial 02 is incompletely reduced, due to leakage of electrons along the respiratory chain, forming ROS such as the superoxide radical (O2), hydrogen peroxide (H202), singlet oxygen, and hydroxyl radical (HO) [1-51.
Mitochondrial GSH is critical to cell viability, especially under experimental conditions involving a disruption of cellular Ca 2 + homeostasis [6] [7] [8] [9] [10] . Only 10-15% of the cellular GSH resides in liver mitochondria, where it is concentrated (10 mM vs. 7 mM in the cytosol) [11] and functions in cellular defense against reactive oxygen species, particularly H202 [8, 12] . Since liver mitochondria do not contain catalase [6] , detoxification of H202 occurs through the GSH peroxidase/reductase redox cycle [ 13, 14] . Loss of mitochondrial GSH could therefore be detrimental to viability, particularly if challenged oxidatively.
We have previously demonstrated a Ca 2+ dependent mechanism for the rapid and nearly complete depletion of mitochondrial GSH. Treatment of isolated mitochondria with Ca 2+ and P~ permeabilizes the inner membrane of mitochondria, releasing small matrix solutes such as GSH and Ca 2+ [15] [16] [17] [18] [19] . This permeability transition is thought to occur through activation or perhaps deregulation by Ca 2+ and Pi of an inner membrane protein that functions as a putative pore. Following permeabilization, mitochondria undergo large amplitude swelling. Both inner membrane permeability and swelling are prevented by nanomolar concentrations of the immunosuppressive cyclic peptide, CsA [15, 16, 20, 21] .
The transport of Ca 2+ by mitochondria is driven by the transmembrane potential [22] [23] [24] [25] . The inward movement of Ca 2+ decreases the transmembrane potential which is restored either by increasing respiratory chain activity or ATP hydrolysis. Since mitochondrial Ca 2+ uptake is closely linked with permeability transition, we examined the effects of treatment with the metabolic inhibitors, antimycin, oligomycin and sulfide, on inner membrane permeability and large amplitude swelling. Antimycin A and sulfide are electron transport inhibitors at complex III and cytochrome oxidase, respectively. Oligomycin inhibits ATP synthase and eventually prevents electron transport by coupled mitochondria [25] .
We have recently reported in a short communication that, during Ca 2÷ and Pi-induced permeability transition, both NADH and NADPH are extensively oxidized and ATP and ADP are depleted within several minutes [26] . This is a novel finding, since Pi-induced permeability transition was not previously thought to alter pyridine nucleotide ratios or adenine nucleotide status. We have also observed conditions in which inner membrane permeability occurs without large amplitude swelling but with loss of calcium and membrane potential [27] . These conditions were observed when mitochondria were treated with either antimycin, oligomycin or sulfide in combination with Ca 2 + and Pi [27] .
Since NAD(H) or NADP(H) (700-835 Da) are normally impermeable to the inner membrane, the possible release of these molecules, as well as glutathione, has been examined during Ca 2+-and P~-induced permeability transition. In addition, we have determined some aspects of the status of both pyridine and adenine nucleotides following treatment with either antimycin, oligomycin or sulfide during Ca 2+-and Pi-induced permeability transition. rats (325-375 g) (Simonsen Labs, Gilroy, CA) were excised and homogenized in isolation buffer containing 220 mM mannitol, 70 mM sucrose, 2 mM Hepes, 0.5 mM EGTA, and 0.5 mg/ml bovine serum albumin (pH 7.4). Mitochondria were washed twice in isolation buffer devoid of EGTA (pH 7.0). After the final wash, the mitochondrial pellets were suspended (25-30 mg/ml) in incubation buffer containing 213 mM mannitol, 71 mM sucrose, 10 mM succinate, and 3 mM Hepes (pH 7.0). Mitochondria prepared by this method contained approx. 10 nmol Ca2+/mg protein. Mitochondrial protein was determined spectrophotometrically by the method of Bradford [29] with bovine serum albumin as the standard.
Mimchondrial incubations
Mitochondria (1 mg protein/ml) were added to 10-ml Erlenmeyer flasks containing incubation buffer plus the various treatments described in the figure legends. After briefly swirling the flask, 1.0 ml samples were taken immediately following the addition of mitochondria. These samples constitute the initial time points. Mitochondrial suspensions were exposed to atmospheric air throughout the remainder of the incubation period. Samples (1 ml) of mitochondrial suspensions, taken at the times indicated in the figure legends, were transferred to 1.5-ml microcentrifuge tubes and immediately centrifuged for 30 s at 13 000 X g. The supernatants were removed for further biochemical analysis where indicated. The remaining mitochondrial pellets were resuspended in either 10% perchloric acid (PCA) and analyzed for GSH, GSSG, adenine and oxidized pyridine nucleotides or in 0.5 M KOH in 50% ethanol and 0.35% cesium chloride for the analysis of reduced pyridine nucleotides as described below.
Materials and methods

Materials
All chemicals were purchased from commercial sources and were of the highest quality available. CsA was a generous gift from Dr. Susan Kohlhepp (Providence Hospital, Portland, OR). CsA was dissolved in 100% ethanol (0.5 mM stock) and stored at 4 ° C. Oligomycin (A,B,C), antimycin A, and sodium sulfide were purchased from Sigma Chemical Company (St. Louis, MO). Aqueous stock solutions of sodium sulfide (0.5 M) were prepared the day of each experiment. Stock solutions of oligomycin (3 mM) and antimycin (1 mM) were dissolved in ethanol.
Preparation of mitochondria
Isolated mitochondria were prepared by differential centrifugation according to the method of Schnaitman and Greenwalt [28] . Briefly, livers from male Sprague-Dawley
Biochemical analysis
GSH was determined by HPLC analysis according to the method of Reed et al. [30] with modifications as described previously [15] . Large amplitude swelling was assessed spectrophotometrically by monitoring the absorbance at 540 nm with an Aminco DW 2000 spectrophotometer operated in split-beam mode of mitochondrial suspensions [31] . Dose concentration of each metabolic inhibitor to be used was established on the basis of their effect on swelling.
Intra-and extra-mitochondrial pyridine and adenine nucleotides were measured according to the HPLC method of Jones [32] with the following modifications to accommodate mitochondrial samples. Briefly, 1 ml samples containing 1 mg protein were removed from the incubation flask at the appropriate time point, transferred to microcentrifuge tubes and centrifuged at 13000Xg for 30 s to separate the suspended mitochondria from the incubation buffer. A sample (0.500 ml) of the supernatant (extra-mitochondrial) was transferred to microcentrifuge tubes con-taining either 0.100 ml 10% perchloric acid (PCA) for the analysis of ATP, ADP, AMP, NADP + and NAD + or 0.100 ml 0.5 M KOH in 50% ethanol and 0.35% cesium chloride for the analysis of NADH and NADPH, and then frozen immediately at -80 ° C. The mitochondrial pellets were suspended in either 0.500 ml 10% PCA for extraction of intramitochondrial ATP, ADP, AMP, NADP +, and NAD + or 0.100 ml 0.5 M KOH in 50% ethanol and 0.35% cesium chloride for extraction of NADPH and NADH. The samples were immediately iced for 15 min, sonicated for 5 s, and then frozen at -80 ° C. Prior to analysis, samples were thawed, the acid extracted samples neutralized with 10 mM KOH and 1 M KH 2 PO4, centrifuged at 13 000 x g for 30 s to remove insoluble debris, and assayed for either NADH and NADPH (base extraction) or NAD +, NADP +, ATP, ADP, and AMP (acid extraction). All samples were assayed by HPLC within 24 h of collection.
Transmission Electron Microscopy (TEM) analysis
Samples (1 mg) for TEM were fixed in 3.0% glutaraldehyde (pH 7.2) for approx. 4 h. Mitochondria were allowed to settle out by gravity and rinsed twice with 0.2 M sodium cacodylate buffer. The rinsed samples were centrifuged at 12500 X g for 10 min. Following centrifugation, the pellet was gently removed and minced into pieces, 1 mm 3. Samples were postfixed in 1.0% OsO 4 for 1 h, rinsed through a graded acetone series, infiltrated with, and embedded in, epoxy resin. Ultrathin sections (60-80 nm) were cut and stained with uranyl acetate and bismuth subnitrate. Specimens were examined with a Ziess EM 10/A transmission electron microscope at an accelerating voltage of 60 kV.
Results
Effect of metabolic inhibitors on GSH, mitochondrial large amplitude swelling and mitochondrial ultrastructure during permeabili~ transition
We have previously reported [15] that during treatment with 70 IzM Ca 2+ and 3 mM Pi (CaPi), isolated mitochondria rapidly ( < 5 min) release approx. 100% of matrix GSH by a CsA-sensitive mechanism. Since the addition of antimycin, sulfide or oligomycin prevented large-amplitude swelling associated with CaPi-induced permeability transition, we determined the status of mitochondrial GSH under these conditions. As shown in Table 1 , treatment with CaP~ resulted in a rapid loss of matrix GSH, as previously reported [15] . The addition of either 0.5 mM sulfide, 3 tzM oligomycin, or 1 p,M antimycin to CaP c treated mitochondria ameliorated CaPi-induced loss of matrix glutathione to varying degrees. The presence of sulfide or oligomycin to CaPi-treated mitochondria inhibited GSH loss more potently than treatment with antimycin ( Table  1 ). The lost GSH was recovered in the extramitochondrial buffer as GSH (data not shown). To determine whether the release of mitochondrial GSH observed following treatment with CaP~ plus either oligomycin, antimycin or sulfide (Table 1 ) occurred through the permeability transition mechanism, 0.5 /zM CsA was included in the incubation. The addition of 0.5 /zM CsA prevented the release of mitochondrial GSH under these conditions (data not shown).
Incubation of mitochondria with CaP i resulted in the rapid decrease in absorbance at 540 nm due to large-amplitude swelling [15, 16] . Addition of 0.5 /zM CsA, a potent inhibitor of the permeability transition, prevented the large-amplitude swelling induced by CaP i [15, 16] . Similarly, the addition of either 0.5 mM sulfide, 3 p.M oligomycin, or 1 tzM antimycin also inhibited CaPi-induced large-amplitude swelling that is generally associated with the permeability transition [27] . Since large-amplitude swelling was not observed in mitochondria treated with CaP i plus the metabolic inhibitors [27] , although inner membrane permeability was observed as indicated by the CsA-sensitive release of GSH (Table 1) , samples were prepared and analyzed by TEM to determine whether morphological changes could be observed under these conditions. Fig. l a shows untreated mitochondria following a 10 min incubation. They have an electron-dense and well-defined ultrastructure, indicating they are functionally and structurally intact and highly energized [33] . Mitochondria (1 mg/ml) were incubated in the absence (control) or presence of either 70 /.LM Ca 2 + and 3 mM Pi (CaPi); 0.5/zM CsA plus Ca Pi; 0.5 mM sulfide plus CaP i (sulfide + CaPi); 3 ~M oligomycin plus CaP i (oligomycin + CaPi); or 1 /xM antimycin plus CaP, (antimycin + CaPi). Samples (1 ml) were taken at the various times indicated and analyzed for GSH, pyridine and adenine nucleotides as described in Section 2, n = 3-4 _+ SE. (Fig. lb) . However, some mitochondria in these populations appear somewhat less electron dense than untreated mitochondria (Fig. la) and are perhaps in the orthodox conformation as opposed to the condensed conformation [33] . These two conformations have been studied by Hackenbrock [33] , who proposed that they are related to either the metabolic state of the mitochondria or the energization of the inner mitochondrial membrane. 
Effect ~0 ¢ Ca 2+ and Pi on adenine and pyridine nucleotides
CaPi-induced permeability transition is accompanied by the rapid and extensive oxidation of NADH and NADPH [23] . Since pyridine nucleotides are relatively small molecules (< 850 Da) and normally impermeable to the inner membrane, we hypothesized that release of pyridine nucleotides occurred through the putative inner membrane pore. To test this hypothesis, both intra-and extra-mitochondrial NAD(H) and NADP(H) levels were measured during permeability transition induced with CaP~. As shown in Table 2 , mitochondrial NADH and NADPH pools are decreased roughly 50% within 5 min following treatment with CaP~. This decrease is not accounted for by an increase in extramitochondrial NADH and NADPH ( Table  2 ). The depletion of NADH and NADPH are nearly accounted for as NAD + and NADP + which are found both intra-and extra-mitochondrially. The addition of 0.5 /zM CsA, a potent inhibitor of permeability transition, prevented the oxidation and release of NAD + and NADP + ( Table 2) .
As shown in Table 2 , the addition of oligomycin (3 ~M), sulfide (0.5 raM) or antimycin (1 p,M) to incubation buffer containing CaP i decreased NADH and NADPH to varying degrees. Treatment with oligomycin and sulfide maintained NADH levels 40% and 20%, respectively, greater than CaP~ treatment alone, whereas the addition of antimycin potentiated the loss of NADH by 20%. The observed loss of NADH and NADPH was not accounted for by the recovery of NADH and NADPH extramitochondrially (Table 2) . With all treatments, the NADH lost was recovered as NAD + and detected both intra-and extramitochondrially (Table 2) . Interestingly, the amount of NAD + detected extramitochondrially does not correspond to the amount of NADH lost. For example, treatment with antimycin resulted in increased formation of NAD + as compared to CaP~ treatment alone, although antimycintreated mitochondria released less NAD + ( Table 2) .
The mitochondrial NADPH pool followed the same pattern of oxidation and release as observed with NADH following treatment of mitochondria with the metabolic inhibitors. The loss of NADPH was accounted for as NADP +, which was recovered both intra-and extramitochondrially ( Table 2 ). The release of NADP + from the matrix followed the same pattern as that observed with NAD + following a 5 min incubation. The observed pattern is that treatment with CaP i resulted in the greatest release of NAD + and NADP +, followed by treatment with antimycin + CaP~, oligomycin + CaP i, and then sulfide + CaP i . Table 1 lists the pyridine nucleotide redox couples of NAD+:NADH and NADP+:NADPH following a 5 rain incubation. Treatment with CaP i resulted in greatly increased ratios of both NAD + :NADH and NADP + :NADPH, as compared to untreated controls and CsA-treated mitochondrial samples. However, the addition of antimycin to CaPi-treated mitochondria resulted in the redox ratios of both NAD + :NADH and NADP + :NADPH greater than that observed with CaP i treatment alone. The addition of oligomycin or sulfide to CaPi-treated mitochondria preserved the NAD+:NADH and NADP+:NADPH:redox couples as compared to CaP i treatment alone (Table 1) . Measurements of ATP, ADP, and AMP with the various treatments are reported in Table 3 . Treatment with CaP~ resulted in the depletion of ATP and ADP by 5 min, with 75% of the adenine pool recovered as AMP (Table 3) . Addition of 0.5 /zM CsA eliminated this effect, resulting in increased levels of ATP, slightly increased levels of ADP, and decreased AMP levels compared to untreated control samples (Table 3) .
The presence of the metabolic inhibitors in addition to CaP i preserved ATP and/or ADP levels compared to CaP i treatment alone (Table 3 ). The addition of 3 /xM oligomycin to CaPi-treated mitochondria maintained ATP levels similar to control values at 5 min, whereas ADP loss was minimal as compared to CaP~ treatment alone. The addition of antimycin (1 /zM), in conjunction with CaP i, did not sustain ATP levels any differently than did CaP~ treatment alone; however, ADP levels were preserved as compared to CaP i treatment alone (Table 3 ).
The energy charge [(ATP + 0.5ADP)/(ATP + ADP + AMP)], which is one designation of energy status, indicated that the presence of antimycin, sulfide, or oligomycin preserved mitochondrial energy to varying degrees compared to CaP~ treatment alone. Following treatment with CaP i, the energy charge dropped to 0.158 as compared to untreated controls (0.351) ( Table 1) . Treatment of mitochondria with either oligomycin, sulfide, or antimycin plus CaP~ resulted in energy charge values of 0.409, 0.209 and 0.169 respectively, following a 5 min incubation (Table 1) .
Discussion
A major finding is the dissociation of inner membrane permeability transition from large-amplitude swelling. As large-amplitude swelling results from the permeabilization of the inner membrane, it is often used to assess whether permeability transition is occurring in mitochondrial samples. As a secondary event to the permeability transition, large-amplitude swelling is thought to occur because matrix proteins are slow to equilibrate through the permeability defect as compared with smaller solutes. This is thought to create a colloid-osmotic pressure imbalance which drives the entrance of water, resulting in dilution of the matrix and massive swelling [18] .
Several previous reports have suggested that both antimycin and oligomycin inhibit permeability transition [34] [35] [36] [37] . These conclusions are based upon the ability of these compounds to prevent large-amplitude swelling. We have recently demonstrated [27] that, although these compounds do prevent large-amplitude swelling, release of both matrix GSH and Ca 2+ occurred by a CsA-sensitive mechanism. This occurred when either antimycin, oligomycin, or sulfide were coincubated in buffer containing CaP i (Table 1) . Under these conditions, the addition of CsA completely prevented GSH, as well as Ca 2÷ release [27] . The prevention by CsA, a potent inhibitor of the permeability transition, suggested that inner membrane permeability occurred in the absence of large-amplitude swelling.
Analysis of mitochondrial samples by TEM also indicated that the morphological alterations observed with CaP i treatment are prevented when metabolic inhibitors are present (Figs. l a-f) . These findings suggest that severe mitochondrial injury, such as the loss of matrix GSH, can occur without obvious morphological changes and, therefore, that it may be necessary to monitor solute release rather than relying solely on ultrastructural analysis such as TEM or light scatter changes at 540 nm to assess inner membrane permeability.
Mitochondria treated with oligomycin, antimycin, or sulfide in buffer containing CaP i appear to be in the orthodox conformation as opposed to the condensed (Figs. ld-f) [33] . Changes in ultrastructure from the condensed to the orthodox conformation are generally associated with a decrease in mitochondrial energy status [33] . Mitochondrial energy status is regulated by several different parameters including adenine and pyridine nucleotides, the ratio of GSH:GSSG as well as the ratio of total thiols:total disulfides and the membrane potential. Recent publications [27, [40] [41] [42] suggest that the collapse of the membrane potential is closely linked with permeability transition. Other studies have also suggested that membrane potential is important in regulating inner membrane permeability [38] [39] [40] .
We have observed that CaP~-induced permeability transition was accompanied by the oxidation of the pyridine nucleotide pool and depletion of ATP [26] , with the selective efflux of NAD ÷ and NADP ÷. These findings do not Support the current thought that CaPi-induced permeability transition does not alter the status of pyridine or adenine nucleotides. Although the mechanism by which CaP~ treatment results in the oxidation of NADH and NADPH is not understood, it does not appear to involve the oxidation of GSH or lipid peroxidation, as no evidence of either has been detected in this model [15] .
We also measured the status of pyridine and adenine nucleotide in mitochondria treated with either oligomycin, sulfide or antimycin in the presence of CaPi. The addition of oligomycin, sulfide or antimycin to CaPctreated mitochondria prevented mitochondrial large-amplitude swelling but not the CsA-sensitive release of GSH and Ca 2÷ [27] . Treatment of mitochondria with oligomycin or sulfide in the presence of CaP i preserved the reduce pyridine nucleotide levels as compared CaP~ alone, but less than untreated control samples. On the other hand, antimycin, in the presence of CaP~, potentiated the decrease in pyridine nucleotides.
The increased oxidation of NADH and NADPH observed with antimycin treatment may be due to an increase in H202. Inhibition of electron transport with antimycin is thought to result in an increase in H202 formation due to the electron leakage at ubiquinone [43, 44] . However, formation of GSSG was not detected and GSH was released to the extramitochondrial environment within 5 rain.
Inducing agents such as t-butyl hydroperoxide or hydrogen peroxide are thought to induce permeability transition due to the oxidation of pyridine nucleotides [18, 41, 45] . However, based on the findings we report, the redox status of pyridine nucleotides alone does not seem to regulate permeability transition. This observation is based on the finding that treatment with antimycin resulted in an increased oxidation of both NADH and NADPH compared to CaP i treatment alone; but, unlike CaP i treatment, the addition of antimycin abolished large-amplitude swelling and solute release was diminished. Although these findings do not dispute the significance of the pyridine nucleotide redox status in contributing to or regulating permeability transition, they do seem to suggest that pyridine nucleotide redox status alone does not determine the degree of permeability transition status, i.e., permeability transition with or without large-amplitude swelling.
In conclusion, we report that during CaPi-induced permeability transition, NADH, NADPH, ATP and ADP are rapidly depleted. Our findings suggest that inner membrane permeability transition can occur in the absence of mitochondrial large-amplitude swelling. We find that CsA-sensitive permeability transition can occur without large-amplitude swelling and that under these conditions, the loss of solute regulation of GSH, Ca 2+ [27] , and perhaps other matrix solutes, is indicated by the release of these molecules. Ultrastructural analysis of mitochondria by TEM or light scatter did not indicate the significant biochemical alterations occurring under the conditions studied. This observation may be important, because mitochondrial integrity is often assessed by TEM and the light scatter assay. We conclude that CsA-sensitive permeability transition occurs without obvious ultrastructural changes. Therefore, monitoring the CsA-sensitive release of concentrated endogenous matrix solutes, such as GSH, may be a sensitive and useful indicator of mitochondrial permeability transition. Under these conditions, NADH and NADPH undergo extensive oxidation with the subsequent release of NAD + and NADP + from the mitochondrial matrix within a 5 rain incubation. This release appears to occur through the putative Ca2+-dependent inner membrane pore as CsA prevented the oxidation and release of pyridine nucleotides. ATP and ADP are also rapidly depleted with the concomitant formation of AMP during CaP i treatment. The addition of either oligomycin, sulfide, or antimycin preserved NADH, NADPH, ATP, and ADP to varying degrees.
